english: What we saw very quickly is the world of both medical research, but also developing drugs and treatments, is dominated by, as you would expect, large organizations, but in a new field, sometimes large organizations really have trouble getting out of their own way, and sometimes they can't ask the right questions, and there is an enormous gap that's just gotten larger between academic research on the one hand and pharmaceutical companies and biotechs that are responsible for delivering all of our drugs and many of our treatments, and so we knew that to really accelerate cures and therapies, we were going to have to address this with two things: new technologies and also a new research model.
non_english: Ono što smo ubrzo shvatili je da su i medicinska istraživanja i proces pronalaženja lekova i tretmana, pod apsolutnom dominacijom velikih organizacija, što biste i očekivali. Ali u novim granama nauke, ponekad te velike organizacije nerado odustaju od starog načina rada, pa nekada ne mogu da postave pravo pitanje i postoji ogromna praznina, koja postaje sve veća, između akademskog istraživanja sa jedne strane i farmaceutskih i biotehnoloških kompanija koje stoje iza proizvodnje velikog dela lekova i mnogih tretmana za naše lečenje. Znali smo da ako želimo zaista ubrzati pronalazak lekova i terapija, treba da razmislimo o ove dve stvari: o novim tehnologijama i  o novim laboratorijskim modelima.